Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
about
Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesDeletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner.Deficiency of CC chemokine ligand 2 and decay-accelerating factor causes retinal degeneration in miceThe complement cascade as a mediator of tissue growth and regeneration.Properdin homeostasis requires turnover of the alternative complement pathwayComplement and HIV-I infection/HIV-associated neurocognitive disorders.An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.Gene Expression Profile of the Hypothalamus in DNP-KLH Immunized Mice Following Electroacupuncture Stimulation.Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression.Role of complement and complement regulatory proteins in the complications of diabetesDecay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanismsDeletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr miceThe complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo.Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.GPI-AP release in cellular, developmental, and reproductive biology.Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndromeMembrane protein Crry maintains homeostasis of the complement system.Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production.Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.Protection of host cells by complement regulators.Direct Binding of the pH-Regulated Protein 1 (Pra1) from Candida albicans Inhibits Cytokine Secretion by Mouse CD4+ T Cells.Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer.Molecular and functional analysis of mouse decay accelerating factor (CD55)Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity.The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia.Correlation between serum estradiol in the follicular phase of the ovarian cycle and decay acceleration factor (DAF) expression on red blood cells and coxsackiervirus B-3 induced hemagglutination in young cycling women.Factors controlling sperm migration through the oviduct revealed by gene-modified mouse models.Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins.Analysis of the promoters and 5'-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes.Decay-accelerating factor 1 deficiency exacerbates Trypanosoma cruzi-induced murine chronic myositis.Maternal pentraxin 3 deficiency compromises implantation in mice.Autoimmunity in Coxsackievirus B3 induced myocarditis: role of estrogen in suppressing autoimmunityEpidemiology and Immune Pathogenesis of Viral Sepsis
P2860
Q24642928-FFCFA417-8E5F-48AA-A86B-5D579F0FD4B6Q28570196-CBE49E67-3D61-4D66-8AC7-CD631217F386Q33405750-75F85A09-CB9F-4977-9AFE-289A7D4DA5B2Q33585843-4DE4BBD4-B4A2-41D1-BD98-96A17B107B41Q33902247-FFD91A54-0F62-4F4D-B776-951F700F416EQ34154941-77374652-D396-4D96-BE3B-D224C562EDF3Q34320277-D415597C-44E2-44DE-A868-665DC3628F6DQ34610122-11860E5E-B2C7-4A5C-9963-2ED1978D89FDQ34775999-5037CFF0-7DDD-4A07-A40A-43908C32CEAEQ35105940-66F8F174-3B2B-4D74-B1CD-83D886E5BE77Q35615765-69FA622F-CA5E-4AB9-8F49-14699EDD5322Q35657115-D8FD3701-707B-4D79-B5AC-C94A42F1280EQ35691607-FAAAA56A-844A-4EE2-9F33-DCBBD1A5E695Q35789124-B1C1AEC6-E4C1-45F2-8FCD-4D972DA0FBFEQ36403243-2B9BC527-CC00-4322-89B2-136830EC32F7Q36563619-F5A283CC-0F12-449D-8952-555C7197B394Q36731806-E351831B-3A6F-4832-8E87-84C72177005DQ36890849-64628F90-DEC7-47AD-9307-49737E901684Q36967101-0939505F-16E9-4442-AFFE-9C140250C535Q37142154-E702ACC1-90FD-47CF-9F2C-DA4DDF729D39Q37248837-E33CAA04-2800-440C-B757-80BA64078DA3Q37291621-DD278079-0B6D-4E9C-BE58-9DDC55BF6F1BQ37362130-397C5571-30C2-4D6A-9B5F-01C905F91E4BQ37365476-37FD1662-03B6-4E64-ACFF-605A273566CFQ37558525-48B152C4-B115-46BF-B57F-347310CD54C9Q38991019-A865AD7B-2A45-4790-81DB-B67683B405EFQ40182286-1D4D788B-FACC-4657-BD11-C21E5BCF66A1Q40497400-E80B24DB-882B-40F3-9122-34606EBED0CBQ41808735-7473A5DC-5CC3-4403-A437-F4361DB2C9B6Q43090515-4E216EE5-E273-4579-B9B9-716D606DEFBAQ43523896-F3D95229-046A-4F9F-9092-425D601E2EE1Q44108310-BD997A1C-C4EC-4503-A4AB-25DDB2B78006Q44776407-6B605AB7-8962-489F-A06B-130C0FA501C4Q47550925-F3AC2505-2E5E-49AD-88C2-A5C4696253CAQ48187016-D457145A-65DE-4CB0-9580-51377897193FQ50739813-00AE0052-6394-4041-B8ED-43F567432131Q50937506-257F72E4-25EB-42B7-A6A3-240AF264D537Q51984522-51091107-E555-4BDB-9B53-47396F6559E5Q57016612-3560B913-90DC-457C-80E1-845F4A34047FQ57490857-8A20BDF9-6226-4762-80CA-2B0D8DACAC60
P2860
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
description
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1999
@ast
im Januar 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/01/19)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/01/19)
@nl
наукова стаття, опублікована в січні 1999
@uk
name
Role of decay-accelerating fac ...... as revealed by gene targeting
@ast
Role of decay-accelerating fac ...... as revealed by gene targeting
@en
Role of decay-accelerating fac ...... as revealed by gene targeting
@nl
type
label
Role of decay-accelerating fac ...... as revealed by gene targeting
@ast
Role of decay-accelerating fac ...... as revealed by gene targeting
@en
Role of decay-accelerating fac ...... as revealed by gene targeting
@nl
prefLabel
Role of decay-accelerating fac ...... as revealed by gene targeting
@ast
Role of decay-accelerating fac ...... as revealed by gene targeting
@en
Role of decay-accelerating fac ...... as revealed by gene targeting
@nl
P2093
P2860
P356
P1476
Role of decay-accelerating fac ...... as revealed by gene targeting
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.2.628
P407
P577
1999-01-01T00:00:00Z